EMAP II human
SIGMA/SRP4463 - recombinant, expressed in E. coli, ≥98% (SDS-PAGE)
Synonym: AIMP1; EMAP2; EMAPII; Multisynthetase complex auxiliary component p43; SCYE1
Product Type: Chemical
| assay | ≥98% (SDS-PAGE) |
| biological source | human |
| form | lyophilized |
| impurities | endotoxin, tested |
| mol wt | ~18.3 kDa |
| NCBI accession no. | Q12904   |
| packaging | pkg of 20 μg |
| potency | 20-40 ng/mL |
| recombinant | expressed in E. coli |
| shipped in | wet ice |
| storage temp. | −20°C |
| UniProt accession no. | Q12904 |
| General description: | Endothelial-Monocyte Activating Polypeptide-II (EMAP-II) is a tumor derived cytokine that is an anti-angiogenic factor in tumor vascular development, and strongly inhibits tumor growth. Recombinant human EMAP-II is an 18.3 kDa protein containing 166 amino acid residues. |
| Physical form: | Lyophilized from a concentrated (1 mg/ml) solution in water containing 20 mM sodium Phosphate buffer pH 7.5 and 130 mM sodium chloride. |
| Reconstitution: | Centrifuge the vial prior to opening. Avoid freeze-thaw cycles. |
| Reconstitution: | Reconstitute in water to a concentration of 0.1-1.0 mg/mL. This solution can then be diluted into other aqueous buffers |
| Purity | ≥98% (SDS-PAGE) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |